Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.63 |
| ▸ | MEN1 | O00255 | 2/20 | 0.63 |
| ▸ | MAPT | P10636 | 2/20 | 0.63 |
| ▸ | THRB | P10828 | 2/20 | 0.63 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.63 |
| ▸ | APEX1 | P27695 | 2/20 | 0.63 |
| ▸ | USP2 | O75604 | 1/20 | 0.63 |
| ▸ | LMNA | P02545 | 1/20 | 0.63 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.63 |
| ▸ | POLB | P06746 | 1/20 | 0.63 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.63 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.63 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.63 |
| ▸ | HPGD | P15428 | 1/20 | 0.63 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.63 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.63 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.63 |
| ▸ | RECQL | P46063 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9609762 | 1.00 | HSD17B10 (0.63) | HSD17B10TDP1MEN1MAPTTHRB | |
| SCHEMBL6413992 | 1.00 | HSD17B10 (0.63) | HSD17B10TDP1MEN1MAPTTHRB | |
| SCHEMBL5447002 | 1.00 | HSD17B10 (0.63) | HSD17B10TDP1MEN1MAPTTHRB | |
| SCHEMBL1603375 | 0.99 | HSD17B10 (0.62) | HSD17B10TDP1MEN1MAPTTHRB | |
| SCHEMBL1603809 | 0.99 | HSD17B10 (0.62) | HSD17B10TDP1MEN1MAPTTHRB | |
| SCHEMBL1602877 | 0.99 | HSD17B10 (0.62) | HSD17B10TDP1MEN1MAPTTHRB | |
| SCHEMBL1603399 | 0.99 | HSD17B10 (0.62) | HSD17B10TDP1MEN1MAPTTHRB | |
| SCHEMBL21051915 | 0.99 | HSD17B10 (0.62) | HSD17B10TDP1MEN1MAPTTHRB | |
| SCHEMBL1603405 | 0.99 | HSD17B10 (0.62) | HSD17B10TDP1MEN1MAPTTHRB | |
| SCHEMBL1603442 | 0.99 | HSD17B10 (0.62) | HSD17B10TDP1MEN1MAPTTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2501 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025224101-A1 | ANTI-VIRAL CONJUGATES | FUNDACAO GIMM - GULBENKIAN INSTITUTE FOR MOLECULAR MEDICINE (PT) | 2025-10-30 | — | — | WO | claimed |
| US-20250242033-A1 | Novel Stannic Protoporfin Compositions, Methods of Making, and Uses Thereof | RENIBUS THERAPEUTICS, INC. | 2025-07-31 | — | — | US | claimed |
| US-20250161235-A1 | STRESS TEST AND TREATMENT OF CHRONIC KIDNEY DISEASE | RENIBUS THERAPEUTICS, INC. | 2025-05-22 | — | — | US | claimed |
| US-12178789-B2 | Stress test and treatment of chronic kidney disease | RENIBUS THERAPEUTICS, INC. (US) | 2024-12-31 | — | — | US | claimed |
| US-20240108589-A1 | STRESS TEST AND TREATMENT OF CHRONIC KIDNEY DISEASE | RENIBUS THERAPEUTICS, INC. | 2024-04-04 | — | — | US | claimed |
| US-11883371-B2 | Stress test and treatment of chronic kidney disease | RENIBUS THERAPEUTICS, INC. (US) | 2024-01-30 | — | — | US | claimed |
| CN-116144650-A | Method for detecting content and/or activity of FTO and subfamily thereof | 东南大学 | 2023-05-23 | — | — | CN | claimed |
| EP-4144379-A1 | CONTRAST AGENT FILM-FORMING AGENT COMPOSITION, CONTRAST AGENT FILM-FORMING LIPID SOLUTION, AND CONTRAST AGENT AND PREPARATION METHOD THEREFOR | Nanjing Transcend Vivoscope Bio-Technology Co., Ltd (CN) | 2023-03-08 | — | — | EP | claimed |
| WO-2023013175-A1 | CATIONIC POLYMER CONTAINING PORPHYRIN, TISSUE MARKING AGENT CONTAINING SAME, AND PHOTOSENSITIZER | 国立研究開発法人物質・材料研究機構 | 2023-02-09 | — | — | WO | claimed |
| EP-4125860-A1 | STRESS TEST AND TREATMENT OF CHRONIC KIDNEY DISEASE | Renibus Therapeutics, Inc. (US) | 2023-02-08 | — | — | EP | claimed |
| WO-1988004174-A1 | USE OF TIN PROTOPORPHYRIN AND TIN MESOPORPHYRIN IN THE TREATMENT OF PSORIASIS | THE ROCKEFELLER UNIVERSITY (US) | 1988-06-16 | — | — | WO | claimed |
| US-4692440-A | Therapeutic use of tin mesoporphyrin | THE ROCKEFELLER UNIVERSITY (US) | 1987-09-08 | — | — | US | claimed |
| US-4675338-A | PEPTIDE LINKAGES WITH ASPARTIC AND GLUTAMIC ACID; ANTITUMOR A GENTS | NIPPON PETROCHEMICALS CO., LTD. (JP) | 1987-06-23 | — | — | US | claimed |
| US-4657902-A | Therapeutic use of tin mesoporphyrin | THE ROCKEFELLER UNIVERSITY (US) | 1987-04-14 | — | — | US | claimed |
| EP-0213272-A2 | New tetrapyrrole polyaminomonocarboxylic acid therapeutic agents | Nippon Petrochemicals Co., Ltd. (JP) | 1987-03-11 | — | — | EP | claimed |
| WO-1986005685-A1 | THERAPEUTIC USE OF TIN MESOPORPHYRIN | THE ROCKEFELLER UNIVERSITY (US) | 1986-10-09 | — | — | WO | claimed |
| EP-0196079-A1 | Therapeutic use of tin mesoporphyrin | THE ROCKEFELLER UNIVERSITY (US) | 1986-10-01 | — | — | EP | claimed |
| US-4610241-A | Atherosclerosis treatment method | GORDON, DAVID, SKOKIE, ILLINOIS | 1986-09-09 | — | — | US | claimed |
| US-4590922-A | INTRACELLULARLY LOCALIZING, THEN INDUCTINELY HEATING | GORDON, DAVID, SKOKIE, ILLINOIS | 1986-05-27 | — | — | US | claimed |
| EP-0168832-A2 | Pharmaceutical composition containing a tetrapyrrole compound as active ingredient and process for the production of the tetrapyrrole compound | Nippon Petrochemicals Co., Ltd. (JP) | 1986-01-22 | — | — | EP | claimed |